Kathmandu. Russia has achieved new success in the fight against cancer. The federal medical and biological agency (FMBA) has developed the cancer vaccine.
“The Russian enteromics cancer vaccine is now ready for use,” fmba chief Veronica Skovotrsova said. This mRNA-based vaccine has successfully undergone all preclinical trials. This proves the safety and efficacy of this vaccine. The initial target of the vaccine will be colorectal cancer. ’
Vaccine passed all trials
Russian news agency TASS reported that Russia’s cancer vaccine has performed well and FMBA chief Veronica Skovotrsova made the announcement at the Eastern Economic Forum (EEF).
Scientists are now awaiting approval
Skovotrsova said, “This research went on for many years. Of these, the last three years were devoted only to compulsory preclinical studies. The vaccine is now ready for use. We are waiting for official approval. ’
“Preclinical trials confirm the vaccine’s safety, despite repeated use, its efficacy,” Skovotrsova said. Researchers observed a decrease in tumor size and a decrease in tumor growth during this period. In addition, studies have also indicated an increase in the survival rate of patients due to vaccination. ’
The initial target of this vaccine will be colorectal cancer. In addition, promising progress has been made in developing vaccines for specific types of melanoma, including glioblastoma (brain cancer) and eye melanoma (a type of eye cancer). which are currently in their advanced stages.
The 10th Eastern Economic Forum was held in Vladivostok from September 3 to 6 under the theme ‘The Far East: Cooperation for Peace and Prosperity’. More than 8,400 people from more than 75 countries and regions participated in this forum.
